Overview

Safety and Efficacy Comparison of TG-873870(Nemonoxacin) to Levofloxacin in Community-Acquired Pneumonia

Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
This study will test the safety and efficacy of TG-873870(Nemonoxacin) compared with Levofloxacin in adult patients with Community-Aquired Pneumonia(CAP)
Phase:
Phase 2
Details
Lead Sponsor:
TaiGen Biotechnology Co., Ltd.
Collaborator:
Quintiles, Inc.
Treatments:
Levofloxacin
Ofloxacin